Prophylactic Iron and Nutrition in Preventing Infant Iron Deficiency

NCT06283342 | Completed

• 1 other identifier: Konya Pediatric Hematology
• Study Type: observational
• Target: 2
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to reveal the effects of prophylactic iron preparations, adequate breast milk intake, and iron-rich supplementary food intake in the prevention of IDA (iron deficiency anemia) and ID (iron deficiency) in infancy.

Conditions

Iron Deficiency Anemia in Childbirth; Infant Nutrition Disorders; Iron Deficiencies

Keywords

prophylactic iron; infant nutrition; iron deficiency prevention; pediatric health

Outcome Measures

Primary Outcomes (1)

• Ferritine level

  Ferritin level below 12 mg/L was considered iron deficiency.

  day 1

Secondary Outcomes (4)

• Hemoglobin level

  day 1

• Prophylactic iron use rate

  15 days

• Iron-sufficient supplementary food intake rate of babies

  15 days

• Breast milk usage rate

  15 days

Study Arms (4)

Iron deficiency group

Patients with a ferritin level below 12 mg/L were considered to have Iron deficiency group.

Not iron deficiency group

Patients with a ferritin level above 12 mg/L were considered to have not iron deficiency group.

Iron deficiency anemia group

Patients with ferritin level below 12 mg/L and hemoglobin (Hb) value below 11 g/dL were considered to have IDA.

Not iron deficiency anemia group

Patients with ferritin level below 12 mg/L and hemoglobin (Hb) value above 11 g/dL were considered to have Not iron deficiency anemia group.

Eligibility Criteria

• Age: 6 Months - 24 Months
• Gender Eligibility Details: Patients aged between 6-24 months and admitted to the general pediatrics outpatient clinic were included in the study
• Age Groups: Child (0-17)
• Sampling Method: Non-Probability Sample

Study Population

Study population include children aged 6-24 months, who were admitted to the general pediatric outpatient clinic of our hospital between January 1st, 2018, and February 1st, 2019.

You may qualify if:

• Patients aged between 6-24 months and admitted to the general pediatrics outpatient clinic

You may not qualify if:

• Chronic disease
• Blood transfusion history,
• Thalassemia carrier status
• Clinical diagnosis of infection or elevated C-reactive protein (CRP)
• Patients who received iron deficiency or iron deficiency anemia treatment
• Those who were born prematurely
• Patients with low birth weight

Sponsors & Collaborators

• Konya Meram State Hospital: lead

Study Sites (1)

Konya Training and Research Hospital

Konya, 42090, Turkey (Türkiye)

Location

Related Publications (1)

• Simsek A, Energin VM. The role of prophylactic iron utilization and nutrition to prevent iron deficiency in infancy: Prospective cohort study. Medicine (Baltimore). 2025 Jun 13;104(24):e42947. doi: 10.1097/MD.0000000000042947.

  PMID: 40527768 DERIVED

MeSH Terms

Conditions

Infant Nutrition Disorders; Iron Deficiencies

Condition Hierarchy (Ancestors)

Nutrition Disorders; Nutritional and Metabolic Diseases; Iron Metabolism Disorders; Metabolic Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: February 20, 2024
• First Posted: February 28, 2024
• Study Start: January 1, 2018
• Primary Completion: January 1, 2019
• Study Completion: February 1, 2019
• Last Updated: February 28, 2024

Record last verified: 2024-02

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)